Stay updated with breaking news from Visma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The recent availability of 3 FDA-approved treatments for patients with spinal muscular atrophy (SMA) has dramatically altered patient outcomes and provided a wealth of new avenues for SMA research.
Alexander Fay, MD, PhD, joined for a Q&A about the current state of spinal muscular atrophy (SMA) treatment and the unanswered questions in the field.
A retrospective, exploratory analysis identifies biomarkers predictive of spinal muscular atrophy (SMA) response to nusinersen and suggests the efficacy of using machine learning algorithms to anticipate patient outcomes.
Global telecoms regulators, industry organisations, carriers, think tanks, partners and analysts shared insights on 5G, future networks and digital innovations.
This week, Apple announced it would offer RCS support starting in 2024. Here's what that means for the future of chat between iOS and Android devices.